Primary Care Pod podcast

New(ish) Drug for MACE Prevention

0:00
15:30
15 Sekunden vorwärts
15 Sekunden vorwärts

Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention).  NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.

 

 

Weitere Episoden von „Primary Care Pod“